Medtronic (NYSE: MDT) reported Q1 EPS of $1.20, $0.09 better than the analyst estimate of $1.11. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.57 billion.

GUIDANCE:

Medtronic sees FY2024 EPS of $5.08-$5.16, versus the consensus of $5.05.

For earnings history and earnings-related data on Medtronic (MDT) click here.